AstraZeneca and Pfizer coronavirus vaccines should be deferred for small group of Australians amid blood clot concerns, advisory group says
3 years, 9 months ago

AstraZeneca and Pfizer coronavirus vaccines should be deferred for small group of Australians amid blood clot concerns, advisory group says

ABC  

Australia’s expert advisory group on vaccines has recommended the COVID-19 vaccine be deferred for people who have a history of specific rare blood clotting disorders. Key points: ATAGI says it has made the recommendation as a "precautionary" measure The recommendation follows concerns from Europe about blood clots post vaccination Experts are waiting for more European data before making their next move This is the first time a warning has been given for COVID-19 vaccines in Australia, and the recommendation applies to both Pfizer and AstraZeneca vaccines, although the current concerns have been focussed on the latter. The Australian Technical Advisory Group on Immunisation said "for the time being, ATAGI recommends that vaccination with any COVID-19 vaccine should be deferred for people who have a history of. ATAGI co-chair Professor Allen Cheng said the clinical advice for both AstraZeneca and Pfizer vaccine was only "precautionary". "As for all vaccines, including COVID-19 vaccines, healthcare providers should be alert for persistent, unexpected and/or severe adverse events following immunisation in their patients, particularly those that occur 1–2 weeks after vaccination," ATAGI's statement said.

Rare Blood Clots Blood Vaccines Covid Know European Cheng Vaccine Astrazeneca Pfizer Clot Professor Cheng  small  coronavirus  covid19  thrombosis  astrazeneca  pfizer  clot  australians  european  group  vaccine  rare  know  vaccines  concerns  cheng  blood  deferred

History of this topic

Do kids still need the COVID-19 vaccine in Australia?
7 months, 1 week ago

Do kids still need the COVID-19 vaccine in Australia?

ABC  

If you're a parent wondering if you should have your child vaccinated against COVID-19, you might have jumped online to find out. The COVID-19 vaccine is not currently recommended for "healthy children", explains Daryl Cheng, an associate professor and immunisation consultant at Surveillance of Adverse Events Following Vaccination In the Community. For those children who have previously received COVID-19 immunisation, …

AstraZeneca's Covid vaccine linked to another rare blood disorder
7 months, 3 weeks ago

AstraZeneca's Covid vaccine linked to another rare blood disorder

India Today  

Over a week after AstraZeneca announced a global withdrawal of its vaccine against coronavirus citing a slowdown in sales and availability of enough options in the market, new research has linked it to a rare disorder. Researchers found that the AstraZeneca vaccine, sold in India under the brand name Covishield, is linked to a rare blood clotting disorder called Vaccine-Induced …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
8 months ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
8 months ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
8 months ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
8 months, 1 week ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18  

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
8 months, 1 week ago

In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
8 months, 1 week ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination
10 months, 3 weeks ago

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination

The Hindu  

One of the largest assessments of its kind, spanning 99 million people and investigating reports of adverse reactions following COVID-19 vaccination, found that instances of Guillain Barre Syndrome, myocarditis, pericarditis and cerebral venous sinus thrombosis were at least 1.5 times more than expected following inoculation with mRNA and ChadOX1 vaccines. The Global Covid Vaccine Safety Project, which made the assessment, …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year, 1 month ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Australian Technical Advisory Group recommends COVID-19 booster for those over 75
1 year, 4 months ago

Australian Technical Advisory Group recommends COVID-19 booster for those over 75

Daily Mail  

Minister Mark Butler urged Aussies to stay up to date on boosters ATAGI released recommendations for those over 75 to get jabbed The federal government's immunisation advisory body says the most vulnerable Australians should arrange to get yet another Covid-19 vaccination booster. The Australian Technical Advisory Group on Immunisation on Friday released fresh recommendations saying all adults over the age …

COVID-19: no need for scaremongering, precautions needed, say health experts
2 years ago

COVID-19: no need for scaremongering, precautions needed, say health experts

The Hindu  

Even as the Central and State governments have called for a general alert over a possible rise in COVID-19 cases, public health experts have warned against scaremongering over COVID-19. Public health experts point out that as the new virus variants coming into circulation are the sub variants of Omicron, which in itself was less lethal than Delta, there was no …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 2 months ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 2 months ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

More people are catching coronavirus a second time, heightening long COVID risk, experts say
2 years, 5 months ago

More people are catching coronavirus a second time, heightening long COVID risk, experts say

LA Times  

Emerging evidence suggests that catching the coronavirus a second time can heighten long-term health risks, a worrisome development as the circulation of increasingly contagious Omicron subvariants leads to greater numbers of Californians being reinfected. So we’ve got to stay on that front footing and continue fighting this thing.” As it relates specifically to long COVID — a condition in which …

Advisers to the FDA back Novavax COVID vaccine
2 years, 7 months ago

Advisers to the FDA back Novavax COVID vaccine

NPR  

Advisers to the FDA back Novavax COVID vaccine Enlarge this image toggle caption Karen Ducey/Getty Images Karen Ducey/Getty Images In a 21-0 vote with one abstention, advisers to the Food and Drug Administration recommended that the agency authorize Novavax's two-dose vaccine against COVID-19. In comments to the committee before its vote, Dr. Peter Marks, the FDA's top vaccine official said, …

Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 7 months ago

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Associated Press  

— Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum …

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 7 months ago

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts

LA Times  

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute …

Experts attribute Victoria's COVID-19 rate rise to change in weather, waning immunity
2 years, 7 months ago

Experts attribute Victoria's COVID-19 rate rise to change in weather, waning immunity

ABC  

As Victorians emerged from two years largely defined by lockdowns, the start of 2022 was marked by the sharp rise and fall of cases as a wave of Omicron swept through. She said there wasn't an "appetite" to bring back restrictions like indoor mask-wearing, but encouraged people to take steps to protect themselves by wearing "high quality, well-ventilating" masks. COVID-19 …

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study
2 years, 8 months ago

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study

India TV News  

A fourth dose of the Pfizer or Moderna COVID-19 vaccine is safe and boosts antibody levels, even higher than that of a third dose, according to the latest results from a nationwide study in the UK. The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 8 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

ATAGI is recommending a fourth COVID-19 vaccine for some Australians. Here's what you need to know
2 years, 9 months ago

ATAGI is recommending a fourth COVID-19 vaccine for some Australians. Here's what you need to know

ABC  

Australians aged 65+ and other vulnerable individuals are set to begin rolling up their sleeves for another COVID-19 vaccine dose in just a couple of weeks. In a bid to increase vaccine protection ahead of winter, the nation's top vaccine advisory group has recommended an additional booster dose for those who are at greatest risk of severe illness from COVID-19. …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'
2 years, 9 months ago

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'

News 18  

The EU’s drug watchdog on Thursday recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. The European Medicines Agency’s human medicines committee “has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Coronavirus updates March 04, 2022
2 years, 10 months ago

Coronavirus updates March 04, 2022

The Hindu  

In 2022, 92% of COVID deaths have been in unvaccinated individuals, Director General of the Indian Council of Medical Research Dr. Balram Bhargava said on Thursday. Here are the latest updates Study Third Covid vaccine dose advised for immunocompromised people: study A third dose of the COVID-19 vaccine is recommended for people with a weakened immune system, especially for organ …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
2 years, 10 months ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

As Covid Third Wave Nears End, Government Deliberates on Boosters for All
2 years, 10 months ago

As Covid Third Wave Nears End, Government Deliberates on Boosters for All

News 18  

As the third wave of the Covid pandemic nears its end in India, top scientists in the government are deliberating over the need for vaccine boosters for all in this situation, sources told CNN-News18. India has seen a widespread outbreak of the fast-spreading Omicron variant of the coronavirus over the past few weeks and its data is being analysed by …

A different COVID-19 vaccine debate: Do we need new shots?
2 years, 11 months ago

A different COVID-19 vaccine debate: Do we need new shots?

LA Times  

A technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company’s facility in Puurs, Belgium. to believe that any kind of vaccination is going to protect people from infection, from mild symptomatic disease, forever.” If the goal is preventing serious illness, “we may not need to be doing as much fine-tuning of the vaccines every time a new …

Can vaccination reduce long effects of Covid-19? Here's what we know
2 years, 11 months ago

Can vaccination reduce long effects of Covid-19? Here's what we know

Hindustan Times  

Vaccination can help reduce the long effects of Covid-19 infection, researchers have found based on data collected from those infected with coronavirus. An Israeli report has surfaced that shows that people vaccinated with both doses of the Pfizer-BioNTech vaccine were much less likely to report long Covid as compared to those unvaccinated. The term ‘long Covid’ refers to a condition …

COVID-19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID-19 vaccines offer lasting protection, claims study

India TV News  

A new research has found that COVID-19 vaccination offers long-lasting protection from the worst outcomes of COVID-19. "This is an excellent example of the wonderful research partnership between the Gillings School and NCDHHS, who are working together to generate the evidence base needed to keep our communities safe," said Penny Gordon-Larsen, PhD, Carla Smith Chamblee Distinguished Professor of Global Nutrition …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine
3 years ago

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine

Firstpost  

The panel cited the risk of rare but sometimes fatal cases of blood clotting as well as a lower level of effectiveness against COVID-19 in the Johnson & Johnson shot Washington: Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, United States health officials …

CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot
3 years ago

CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot

Huff Post  

LOADING ERROR LOADING Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don’t come with that risk and also appear …

CDC recommends Pfizer, Moderna COVID-19 shots over J&J’s
3 years ago

CDC recommends Pfizer, Moderna COVID-19 shots over J&J’s

LA Times  

The Johnson & Johnson shot in rare cases has been found to cause serious blood clots. Most Americans should be given the Pfizer-BioNTech or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday. The unusual clotting problem has caused nine confirmed deaths after J&J vaccinations, while the …

South African Regulator Approves Pfizer Booster Vaccine After Surge In Covid Cases
3 years, 1 month ago

South African Regulator Approves Pfizer Booster Vaccine After Surge In Covid Cases

News 18  

South Africa has approved the use of Pfizer’s coronavirus booster vaccine for people aged over 18 years, amid mounting concern following a record of almost 20,000 infections overnight, largely ascribed to the new and highly-mutating Omicron variant. The South African Health Products Authority on Wednesday approved the use of Pfizer’s Comirnaty COVID-19 vaccine after BioNTech and Pfizer announced that two …

Research shows huge benefit of COVID-19 booster shots
3 years, 1 month ago

Research shows huge benefit of COVID-19 booster shots

LA Times  

In research likely to galvanize U.S. support for booster shots, scientists found that Israel’s aggressive campaign to shore up waning coronavirus immunity with a third dose of COVID-19 vaccine has saved lives and reduced new infections across the age spectrum. Coincidentally, the new research comes on a day when Pfizer and BioNTech acknowledged that two doses of its vaccine “may …

Mounting evidence highlights the importance of Covid-19 boosters
3 years, 1 month ago

Mounting evidence highlights the importance of Covid-19 boosters

CNN  

CNN — As the world learns more about the Omicron coronavirus variant and Delta continues to cause Covid-19 cases to rise around much of the United States, the need for booster shots becomes clearer than ever – even beyond the growing data about waning vaccine immunity. “But also I do hope that our federal health officials will be quick to …

Booster dose of six Covid vaccines safe, increases immunity: Lancet study
3 years, 1 month ago

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Deccan Chronicle  

New Delhi: Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in The Lancet journal. Two doses of AstraZeneca and Pfizer vaccines have shown 79 per cent and 90 per cent protection, respectively, against hospitalisation and death after six …

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?
3 years, 1 month ago

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?

ABC  

The Omicron variant has been generating anxiety across the world since being declared a COVID-19 variant of concern by the World Health Organization over the weekend. According to Westmead Institute virologist Tony Cunningham, scientists around the world — including those in Australia — would be looking at whether protective antibodies in the vaccines were "sufficiently high" to cover this strain. …

AstraZeneca age group has fewer antibodies against corona, blood bank finds
3 years, 2 months ago

AstraZeneca age group has fewer antibodies against corona, blood bank finds

Dutch News  

People in their early sixties, the age group that was given the AstraZeneca vaccine, have fewer antibodies against coronavirus than other vaccinated groups, according to national blood bank Sanquin. A study of around 1,400 samples from blood donors found that people in the 18 to 25 age group had on average eight times as many antibodies as people aged 61 …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 2 months ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

COVID-19 cases to place further strain on hospitals, AMA warns, as SA boosts vaccine program
3 years, 2 months ago

COVID-19 cases to place further strain on hospitals, AMA warns, as SA boosts vaccine program

ABC  

The Australian Medical Association has expressed severe doubts about the capacity of South Australia's health system to cope with an anticipated influx of COVID-19 cases once border restrictions are repealed later this month. Key points: SA is currently COVID-free but is preparing to repeal border restrictions on November 23 The AMA's Public Hospital Report Card has provided a snapshot into …

Australia adds Covaxin to list of 'recognised' COVID-19 vaccines
3 years, 2 months ago

Australia adds Covaxin to list of 'recognised' COVID-19 vaccines

Deccan Chronicle  

Canberra: Australian government on Monday gave recognition to Bharat Biotech's Covaxin COVID-19 vaccine for the purpose of establishing a traveller's vaccination status in the country. "Today, the Therapeutic Goods Administration determined that Covaxin vaccine would be 'recognised' for the purpose of establishing a traveller's vaccination status," Australia's High Commissioner to India Barry O'Farrell informed in a tweet. "In recent weeks, …

Discover Related